Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Frequency of impaired mephenytoin 4'-hydroxylation in an Indian population.

Literature DB >> 2271379

Frequency of impaired mephenytoin 4'-hydroxylation in an Indian population.

B S Doshi, R D Kulkarni, B L Chauhan, G R Wilkinson.

Abstract

Entities: Chemical

Mesh：

Substances：
Mephenytoin

Year: 1990 PMID： 2271379 PMCID： PMC1368181 DOI： 10.1111/j.1365-2125.1990.tb03850.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

10 in total

Review 1. The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects.

Authors: M Eichelbaum; A S Gross
Journal: Pharmacol Ther Date: 1990 Impact factor: 12.310

Review 2. Genetic polymorphism of S-mephenytoin hydroxylation.

Authors: G R Wilkinson; F P Guengerich; R A Branch
Journal: Pharmacol Ther Date: 1989 Impact factor: 12.310

3. Low frequency of slow debrisoquine hydroxylation in a native Chinese population.

Authors: Y C Lou; L Ying; L Bertilsson; F Sjöqvist
Journal: Lancet Date: 1987-10-10 Impact factor: 79.321

4. Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicin.

Authors: H H Zhou; L B Anthony; A J Wood; G R Wilkinson
Journal: Br J Clin Pharmacol Date: 1990-09 Impact factor: 4.335

5. Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations.

Authors: K Nakamura; F Goto; W A Ray; C B McAllister; E Jacqz; G R Wilkinson; R A Branch
Journal: Clin Pharmacol Ther Date: 1985-10 Impact factor: 6.875

6. Mephenytoin hydroxylation in the Cuna Amerindians of Panama.

Authors: T Inaba; L F Jorge; T D Arias
Journal: Br J Clin Pharmacol Date: 1988-01 Impact factor: 4.335

7. Reconstruction of human evolution: bringing together genetic, archaeological, and linguistic data.

Authors: L L Cavalli-Sforza; A Piazza; P Menozzi; J Mountain
Journal: Proc Natl Acad Sci U S A Date: 1988-08 Impact factor: 11.205

8. Effects of ketoconazole on the polymorphic 4-hydroxylations of S-mephenytoin and debrisoquine.

Authors: J O Atiba; T F Blaschke; G R Wilkinson
Journal: Br J Clin Pharmacol Date: 1989-08 Impact factor: 4.335

9. Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese.

Authors: Y Horai; M Nakano; T Ishizaki; K Ishikawa; H H Zhou; B I Zhou; C L Liao; L M Zhang
Journal: Clin Pharmacol Ther Date: 1989-08 Impact factor: 6.875

10. Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism.

Authors: P J Wedlund; W S Aslanian; C B McAllister; G R Wilkinson; R A Branch
Journal: Clin Pharmacol Ther Date: 1984-12 Impact factor: 6.875

10 in total

6 in total

Review 1. Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.

Authors: I Fricke-Galindo; C Céspedes-Garro; F Rodrigues-Soares; M E G Naranjo; Á Delgado; F de Andrés; M López-López; E Peñas-Lledó; A LLerena
Journal: Pharmacogenomics J Date: 2015-10-27 Impact factor: 3.550